Loading publications…
The last 5 uploaded publications
Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial
Bo Xu, Shengxian Tu, Lei Song, Zening Jin, Bo Yu, Guosheng Fu, Yujie Zhou, Jianan Wang, Yundai Chen, Jun Pu, Lianglong Chen, Xinkai Qu, Junqing Yang, Xuebo Liu, Lijun Guo, Chengxing Shen, Yao‐Jun Zhang, Qi Zhang, Hongwei Pan, Xiaogang Fu, Jian Liu, Yanyan Zhao, Javier Escaned, Yang Wang, William F. Fearon, Kefei Dou, Ajay J. Kirtane, Yongjian Wu, Patrick W. Serruys, Weixian Yang, William Wijns, Changdong Guan, Martin B. Leon, Shubin Qiao, Gregg W. Stone (2021). Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial. The Lancet, 398(10317), pp. 2149-2159, DOI: 10.1016/s0140-6736(21)02248-0.
Article146 days agoDiagnostic performance of angiography-derived fractional flow reserve: a systematic review and Bayesian meta-analysis
Carlos Collet, Yoshinobu Onuma, Jeroen Sonck, Taku Asano, Bert Vandeloo, Ran Kornowski, Shengxian Tu, Jelmer Westra, Niels Ramsing Holm, Bo Xu, Robbert J. de Winter, Jan G.P. Tijssen, Yosuke Miyazaki, Yuki Katagiri, Erhan Tenekecioğlu, Rodrigo Modolo, Ply Chichareon, Bernard Cosyns, Daniel Schoors, Bram Roosens, Stijn Lochy, Jean‐François Argacha, Alexandre van Rosendael, Jeroen J. Bax, Johan H. C. Reiber, Javier Escaned, Bernard De Bruyne, William Wijns, Patrick W. Serruys (2018). Diagnostic performance of angiography-derived fractional flow reserve: a systematic review and Bayesian meta-analysis. European Heart Journal, 39(35), pp. 3314-3321, DOI: 10.1093/eurheartj/ehy445.
Article146 days agoThe Impact of Coronary Physiology on Contemporary Clinical Decision Making
Norihiro Kogame, Masafumi Ono, Hideyuki Kawashima, Mariusz Tomaniak, Hironori Hara, Jonathan Leipsic, Daniele Andreini, Carlos Collet, Manesh R. Patel, Shengxian Tu, Bo Xu, Christos V. Bourantas, Amir Lerman, Jan J. Piek, Justin E. Davies, Javier Escaned, William Wijns, Yoshinobu Onuma, Patrick W. Serruys (2020). The Impact of Coronary Physiology on Contemporary Clinical Decision Making. КАРДИОЛОГИЯ УЗБЕКИСТАНА, 13(14), pp. 1617-1638, DOI: 10.1016/j.jcin.2020.04.040.
Article146 days agoQuantitative flow ratio–guided strategy versus angiography-guided strategy for percutaneous coronary intervention: Rationale and design of the FAVOR III China trial
Lei Song, Shengxian Tu, Zhongwei Sun, Yang Wang, Daixin Ding, Changdong Guan, Lihua Xie, Javier Escaned, William F. Fearon, Ajay J. Kirtane, Patrick W. Serruys, William Wijns, Stephan Windecker, Martin B. Leon, Gregg W. Stone, Shubin Qiao, Bo Xu (2020). Quantitative flow ratio–guided strategy versus angiography-guided strategy for percutaneous coronary intervention: Rationale and design of the FAVOR III China trial. American Heart Journal, 223, pp. 72-80, DOI: 10.1016/j.ahj.2020.02.015.
Article146 days agoNine-month angiographic and two-year clinical follow-up of polymer-free sirolimus-eluting stent versus durable-polymer sirolimus-eluting stent for coronary artery disease: the Nano randomized trial
Yao‐Jun Zhang, Fang Chen, Takashi Muramatsu, Bo Xu, Zhanquan Li, Junbo Ge, Qing He, Zhi-Jian Yang, Shumei Li, Lefeng Wang, Haichang Wang, Ben He, Kang Li, Guoxian Qi, Tianchang Li, Hesong Zeng, Jianjun Peng, Tieming Jiang, Qiutang Zeng, Jianhua Zhu, Guosheng Fu, Christos V. Bourantas, Patrick W. Serruys, Yong Huo (2014). Nine-month angiographic and two-year clinical follow-up of polymer-free sirolimus-eluting stent versus durable-polymer sirolimus-eluting stent for coronary artery disease: the Nano randomized trial. Chinese Medical Journal, 127(11), pp. 2153-2158, DOI: 10.3760/cma.j.issn.0366-6999.20133148.
Article146 days ago